PRAX News and Press, Praxis Precision Medicines Inc. From 12/09/25

2025-12-09 12:06:21 ET from Jefferies issued a price target of $450.00 for PRAX on 2025-12-09 16:01:12. The adjusted price target was set to $450.00. At the time of the announcement, PRAX was trading at $264.395. The overall price target consensus is at $388.80 with high...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 33.6% to $0.0489 on volume of 1,320,857,302 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 2.7% to $2.93 on volume of 288,725,865 shares NVIDIA Corporation (NVDA) rose ...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 28.7% to $0.0471 on volume of 1,267,429,086 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 1.3% to $2.9699 on volume of 260,909,941 shares NVIDIA Corporation (NVDA) ros...

2025-12-08 10:06:22 ET from Truist Financial issued a price target of $500.00 for PRAX on 2025-12-08 14:19:55. The adjusted price target was set to $500.00. At the time of the announcement, PRAX was trading at $273.11. The overall price target consensus is at $352.00 wit...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 16.2% to $0.0366 on volume of 1,054,633,808 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 3.5% to $3.01 on volume of 300,156,120 shares Warner Bros. Discovery Inc. (WB...

Positive Results in the EMBOLD study of relutrigine showed a 53% placebo-adjusted reduction in seizures (p < 0.0002), 66% increase in motor seizure-free days (p = 0.0340), broad and clinically meaningful functional improvements (p ≤ 0.002) Patients in the RADIANT study of ...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 17.5% to $0.037 on volume of 1,002,607,027 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 4.3% to $2.985 on volume of 267,033,397 shares Warner Bros. Discovery Inc. (WB...

2025-12-05 14:39:23 ET Investment Overview - Praxis Caps Off Incredible Year With Another Study Success Read the full article on Seeking Alpha For further details see: Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026

2025-12-05 09:06:32 ET from Deutsche Bank issued a price target of $303.00 for PRAX on 2025-12-05 13:37:32. The adjusted price target was set to $303.00. At the time of the announcement, PRAX was trading at $264.87. The overall price target consensus is at $338.86 with h...

2025-12-05 08:06:36 ET from Wedbush issued a price target of $83.00 for PRAX on 2025-12-05 12:43:26. The adjusted price target was set to $83.00. At the time of the announcement, PRAX was trading at $189.97. The overall price target consensus is at $369.00 with high pric...